Insider · CIK 0001566617
Scott Thomas Jackson
director
Files at MGNX (MACROGENICS INC), SPRO (Spero Therapeutics, Inc.), MURA (Mural Oncology plc). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | MURA Mural Oncology plc | DDisposition to issuer Stock Option (right to buy)derivative | -8,637 | - | - | 0 | Dec 5, 2025 |
| Dec 5, 2025 | MURA Mural Oncology plc | DDisposition to issuer Stock Option (right to buy)derivative | -8,462 | - | - | 0 | Dec 5, 2025 |
| Dec 5, 2025 | MURA Mural Oncology plc | DDisposition to issuer Stock Option (right to buy)derivative | -15,021 | - | - | 0 | Dec 5, 2025 |
| Jun 12, 2025 | SPRO Spero Therapeutics, Inc. | AGrant or award Common Stock | +20,000 | $0.00 | $0 | 75,000 | Jun 16, 2025 |
| Jun 11, 2025 | MURA Mural Oncology plc | AGrant or award Stock Option (right to buy)derivative | +8,637 | $0.00 | $0 | 8,637 | Jun 13, 2025 |
| May 20, 2025 | MGNX MACROGENICS INC | MOption exercise Common Stock | +6,500 | - | - | 11,000 | May 22, 2025 |
| May 20, 2025 | MGNX MACROGENICS INC | MOption exercise Restricted Stock Unitderivative | -6,500 | $0.00 | $0 | 0 | May 22, 2025 |
| May 21, 2025 | MGNX MACROGENICS INC | AGrant or award Restricted Stock Unitderivative | +3,750 | $0.00 | $0 | 3,750 | May 22, 2025 |
| May 21, 2025 | MGNX MACROGENICS INC | AGrant or award Stock Option (right to buy)derivative | +22,000 | $0.00 | $0 | 22,000 | May 22, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.